Abstract:
Objective To investigate the association between changes in frailty status and the risk of developing chronic lung diseases (CLD) among individuals aged ≥ 50 years in China and the United States, providing evidence to support early identification and targeted interventions for high-risk populations.
Methods Data of 6 338 individuals aged ≥ 50 years from four waves of the China Health and Retirement Longitudinal Study (CHARLS) conducted between 2011 and 2018 and 6 465 individuals aged ≥ 50 years from fourteen waves of the U.S. Health and Retirement Study (HRS) conducted between 2006 and 2018 were collected. A prospective cohort design was employed to assess frailty status in both cohorts based on the frailty index (FI). Participants were classified into three categories–robust, pre-frail, and frail participants–based on their FI values. Changes in frailty status were evaluated by comparing FI values at baseline and at two subsequent assessments–the second and the final survey waves. Multivariable Cox proportional hazards regression models were adopted to examine the association between changes in frailty status and the incidence risk of CLD.
Results In the CHARLS baseline survey, frail, pre-frail, and robust participants accounted for 11.2% (709/6 338), 45.3% (2 871/6 338), and 43.5% (2 758/6 338), respectively. During follow-up, participants who remained robust, maintained frailty, progressed to pre-frailty or frailty, and recovered to pre-frailty or robustness constituted 19.8% (1 254/6 338), 3.0% (192/6 338), 20.3% (1 289/6 338), and 5.9% (371/6 338), respectively. In the HRS baseline survey, frail, pre-frail, and robust participants accounted for 27.5% (1 778/6 465), 46.7% (3 018/6 465), and 25.8% (1 669/6 465), respectively. During follow-up, participants who remained robust, maintained frailty, progressed to pre-frailty or frailty, and recovered to pre-frailty or robustness constituted 9.1% (585/6 465), 16.5% (1 064/6 465), 15.6% (1 006/6 465), and 3.1% (202/6 465), respectively. The CLD incidence among those who remained robust, maintained frailty, progressed to pre-frailty or frailty, and recovered to pre-frailty or robustness was 5.7% (71/1 254), 21.9% (42/192), 12.7% (164/1 289), and 13.5% (50/371), respectively, in CHARLS and 1.9% (11/585), 18.0% (191/1 064), 8.0% (80/1 006), and 7.9% (16/202), respectively, in HRS. After adjusting for potential confounders including sex, age, educational attainment, marital status, smoking status, alcohol consumption, physical activity level, body mass index, glycated hemoglobin, high-density lipoprotein cholesterol, serum cystatin C, and C-reactive protein, multivariable Cox proportional hazards regression analysis revealed that in CHARLS and HRS, the hazard ratios (HRs) for CLD incidence among participants who progressed to pre-frailty or frailty were 2.40 (95%CI: 1.85–3.21) and 3.87 (95%CI: 2.06–7.29), respectively, relative to those who remained robust. Among participants who recovered to pre-frailty or robustness, the HRs for CLD incidence were 0.63 (95%CI: 0.42–0.94) in CHARLS and 0.41 (95%CI: 0.27–0.63) in HRS, relative to maintained frailty. Stratified analyses showed that the HRs for CLD incidence among males, females, participants aged ≤ 65 years, and participants aged > 65 years who progressed to pre-frailty or frailty were 2.15 (95%CI: 1.53–3.00), 3.05 (95%CI: 1.82–5.10), 2.34 (95%CI: 1.74–3.15), and 3.03 (95%CI: 1.42–6.49), respectively, in CHARLS and 2.57 (95%CI: 1.14–5.80), 5.88 (95%CI: 2.10–16.42), 3.26 (95%CI: 1.58–6.74), and 5.65 (95%CI: 1.36–23.42), respectively, in HRS. Furthermore, in CHARLS and HRS, the HRs for CLD incidence among females who recovered to pre-frailty or robustness were 0.58 (95%CI: 0.34–0.93) and 0.39 (95%CI: 0.23–0.65), respectively, relative to those who maintained frailty. In HRS, the HRs for CLD incidence among participants aged ≤ 65 years and > 65 years who recovered to pre-frailty or robustness were 0.45 (95%CI: 0.26–0.80) and 0.35 (95%CI: 0.18–0.70), respectively, relative to those who maintained frailty.
Conclusions The trend of association between China and the United States is consistent, and changes in frailty status are an independent risk factor for the development of CLD.